# Intranasal Sphenopalatine Ganglion Blockade for Headaches Following Aneurysmal Subarachnoid Hemorrhage

> **NCT07116408** · PHASE4 · RECRUITING · sponsor: **Wright State University** · enrollment: 20 (estimated)

## Conditions studied

- Aneurysmal Subarachnoid Hemorrhage (aSAH)
- Headache

## Interventions

- **DRUG:** Lidocaine (drug)
- **DEVICE:** Tx 360

## Key facts

- **NCT ID:** NCT07116408
- **Lead sponsor:** Wright State University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-20
- **Primary completion:** 2026-11
- **Final completion:** 2027-05
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07116408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07116408, "Intranasal Sphenopalatine Ganglion Blockade for Headaches Following Aneurysmal Subarachnoid Hemorrhage". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07116408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*